SEARCH

SEARCH BY CITATION

References

  • Ansai T., Dupuy L. C. and Barik S. (1996) Interactions between a minimal protein serine/threonine phosphatase and its phosphopeptide substrate sequence. J. Biol. Chem. 271, 2440124407.
  • Bain D. L., Heneghan A. F., Connaghan-Jones K. D. and Miura M. T. (2007) Nuclear receptor structure: implications for function. Annu. Rev. Physiol. 69, 201220.
  • Balbach J., Steegborn C., Schindler T. and Schmid F. X. (1999) A protein folding intermediate of ribonuclease T1 characterized at high resolution by 1D and 2D real-time NMR spectroscopy. J. Mol. Biol. 285, 829842.
  • Barden N., Stec I. S., Montkowski A., Holsboer F. and Reul J. M. (1997) Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology 66, 212220.
  • Baughman G., Wiederrecht G. J., Chang F., Martin M. M. and Bourgeois S. (1997) Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition. Biochem. Biophys. Res. Commun. 232, 437443.
  • Billing A. M., Fack F., Renaut J., Olinger C. M., Schote A. B., Turner J. D. and Muller C. P. (2007) Proteomic analysis of the cortisol-mediated stress response in THP-1 monocytes using DIGE technology. J. Mass Spectrom. 42, 14331444.
  • Billing A. M., Fack F., Turner J. D. and Muller C. P. (2011) Cortisol is a potent modulator of lipopolysaccharide-induced interferon signaling in macrophages. Innate Immun 17, 302320.
  • Binder E. B. (2009) The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34, S186S195.
  • Binder E. B., Salyakina D. and Lichtner P. et al. (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36, 13191325.
  • Binder E. B., Bradley R. G. and Liu W. et al. (2008) Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 12911305.
  • Binder E. B., Kunzel H. E., Nickel T., Kern N., Pfennig A., Majer M., Uhr M., Ising M. and Holsboer F. (2009) HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 34, 99109.
  • Boyle M. P., Brewer J. A., Funatsu M., Wozniak D. F., Tsien J. Z., Izumi Y. and Muglia L. J. (2005) Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl Acad. Sci. USA 102, 473478.
  • Brent D., Melhem N., Ferrell R. et al. (2010) Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am. J. Psychiatry 167, 190197.
  • Buchanan T. W. (2007) Retrieval of emotional memories. Psychol. Bull. 133, 761779.
  • Carrasco G. A. and Van de Kar L. D. (2003) Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463, 235272.
  • Chambraud B., Belabes H., Fontaine-Lenoir V., Fellous A. and Baulieu E. E. (2007) The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation. Faseb J. 21, 27872797.
  • Cheng R., Juo S. H. and Loth J. E. et al. (2006) Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 11, 252260.
  • Cheung-Flynn J., Prapapanich V., Cox M. B., Riggs D. L., Suarez-Quian C. and Smith D. F. (2005) Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol. Endocrinol. 19, 16541666.
  • Cioffi D. L., Hubler T. R. and Scammell J. G. (2011) Organization and function of the FKBP52 and FKBP51 genes. Curr. Opin. Pharmacol. 11, 308313.
  • Claes S. (2009) Glucocorticoid receptor polymorphisms in major depression. Ann. NY Acad. Sci. 1179, 216228.
  • Colo G. P., Rubio M. F., Nojek I. M., Werbajh S. E., Echeverria P. C., Alvarado C. V., Nahmod V. E., Galigniana M. D. and Costas M. A. (2008) The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action. Oncogene 27, 24302444.
  • Consortium W. T. C. C. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661678.
  • Cox M. B. and Smith D. F. (2007) Functions of the Hsp90-Binding FKBP Immunophilins, in The Networking of Chaperones by Cochaperones (Blatch G. L. ed.), pp. 13–25. Austin, Texas. Eurekah.com.
  • Cox M. B., Riggs D. L., Hessling M., Schumacher F., Buchner J. and Smith D. F. (2007) FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity. Mol. Endocrinol. 21, 29562967.
  • Czar M. J., Owens-Grillo J. K., Yem A. W., Leach K. L., Deibel Jr M. R.., Welsh M. J. and Pratt W. B. (1994) The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol. Endocrinol. 8, 17311741.
  • Das A. K., Helps N. R., Cohen P. T. and Barford D. (1996) Crystal structure of the protein serine/threonine phosphatase 2C at 2.0 A resolution. EMBO J. 15, 67986809.
  • Davies T. H. and Sanchez E. R. (2005) Fkbp52. Int. J. Biochem. Cell Biol. 37, 4247.
  • Davies T. H., Ning Y. M. and Sanchez E. R. (2002) A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J. Biol. Chem. 277, 45974600.
  • Davies T. H., Ning Y. M. and Sanchez E. R. (2005) Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry 44, 20302038.
  • De Iudicibus S., Franca R., Martelossi S., Ventura A. and Decorti G. (2011) Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J. Gastroenterol. 17, 10951108.
  • De Kloet E. R., Vreugdenhil E., Oitzl M. S. and Joels M. (1998) Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19, 269301.
  • Denny W. B., Valentine D. L., Reynolds P. D., Smith D. F. and Scammell J. G. (2000) Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 141, 41074113.
  • Denny W. B., Prapapanich V., Smith D. F. and Scammell J. G. (2005) Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity. Endocrinology 146, 31943201.
  • Doczi J., Turiak L., Vajda S. et al. (2011) Complex contribution of cyclophilin D to Ca2+-induced permeability transition in brain mitochondria, with relation to the bioenergetic state. J. Biol. Chem. 286, 63456353.
  • Echeverria P. C. and Picard D. (2010) Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility. Biochim. Biophys. Acta. 1803, 641649.
  • Echeverria P. C., Mazaira G., Erlejman A., Gomez-Sanchez C., Piwien Pilipuk G. and Galigniana M. D. (2009) Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta. Mol. Cell. Biol. 29, 47884797.
  • Escriva H., Bertrand S. and Laudet V. (2004) The evolution of the nuclear receptor superfamily. Essays Biochem. 40, 1126.
  • Evans R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889895.
  • Fischer G. and Aumuller T. (2003) Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 148, 105150.
  • Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T. and Schmid F. X. (1989) Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337, 476478.
  • Friedman D. B. and Lilley K. S. (2008) Optimizing the difference gel electrophoresis (DIGE) technology. Methods Mol. Biol. 428, 93124.
  • Fusco D., Vargiolu M., Vidone M. et al. (2010) The RET51/FKBP52 complex and its involvement in Parkinson disease. Hum. Mol. Genet. 19, 28042816.
  • Galat A. (2004) A note on clustering the functionally-related paralogues and orthologues of proteins: a case of the FK506-binding proteins (FKBPs). Comput. Biol. Chem. 28, 129140.
  • Galigniana M. D. (1998) Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases. Biochem. J. 333, 555563.
  • Galigniana M. D. and Piwien Pilipuk G. (2004) Activation of the ligand-mineralocorticoid receptor functional unit by ancient, classical, and novel ligands. Structure-activity relationship Vitam. Horm. 69, 3168.
  • Galigniana M. D. and Piwien-Pilipuk G. (1999) Comparative inhibition by hard and soft metal ions of steroid-binding capacity of renal mineralocorticoid receptor cross-linked to the 90-kDa heat-shock protein heterocomplex. Biochem. J. 341, 585592.
  • Galigniana M. D., Housley P. R., DeFranco D. B. and Pratt W. B. (1999) Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J. Biol. Chem. 274, 1622216227.
  • Galigniana M. D., Vicent G. P., Piwien-Pilipuk G., Burton G. and Lantos C. P. (2000) Mechanism of action of the potent sodium-retaining steroid 11, 19-oxidoprogesterone. Mol. Pharmacol. 58, 5870.
  • Galigniana M. D., Radanyi C., Renoir J. M., Housley P. R. and Pratt W. B. (2001) Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J. Biol. Chem. 276, 1488414889.
  • Galigniana M. D., Harrell J. M., Murphy P. J., Chinkers M., Radanyi C., Renoir J. M., Zhang M. and Pratt W. B. (2002) Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain. Biochemistry 41, 1360213610.
  • Galigniana M. D., Harrell J. M., O’Hagen H. M., Ljungman M. and Pratt W. B. (2004a) Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J. Biol. Chem. 279, 2248322489.
  • Galigniana M. D., Morishima Y., Gallay P. A. and Pratt W. B. (2004b) Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex. J. Biol. Chem. 279, 5575455759.
  • Galigniana M. D., Piwien Pilipuk G., Kanelakis K. C., Burton G. and Lantos C. P. (2004c) Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnanesteroids. Mol. Cell. Endocrinol. 217, 167179.
  • Galigniana M. D., Erlejman A. G., Monte M., Gomez-Sanchez C. and Piwien-Pilipuk G. (2010) The hsp90-FKBP52 Complex Links the Mineralocorticoid Receptor to Motor Proteins and Persists Bound to the Receptor in Early Nuclear Events. Mol. Cell. Biol. 30, 12851298.
  • Gallo L. I., Ghini A. A., Pilipuk G. P. and Galigniana M. D. (2007) Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity. Biochemistry 46, 1404414057.
  • Gallo L. I., Lagadari M., Piwien-Pilipuk G. and Galigniana M. D. (2011) TPR-domain immunophilin FKBP51 is a major mitochondrial protein that protects cells from oxidative stress. J. Biol. Chem. 286, 3015230160.
  • Groeneweg F. L., Karst H., de Kloet E. R. and Joels M. (2011) Rapid non-genomic effects of corticosteroids and their role in the central stress response. J. Endocrinol. 209, 153167.
  • Groeneweg F. L., Karst H., de Kloet E. R. and Joels M. (2012) Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol. Cell. Endocrinol. 350, 299309.
  • Handschumacher R. E., Harding M. W., Rice J., Drugge R. J. and Speicher D. W. (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226, 544547.
  • Hartmann J., Wagner K. V., Liebl C. et al. (2012) The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62, 332339.
  • Hawkins G. A., Lazarus R., Smith R. S., Tantisira K. G., Meyers D. A., Peters S. P., Weiss S. T. and Bleecker E. R. (2009) The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J. Allergy Clin. Immunol. 123, 1376–1383.
  • Heim C. and Nemeroff C. B. (2009) Neurobiology of posttraumatic stress disorder. CNS Spectr. 14, 1324.
  • Hilser V. J. and Thompson E. B. (2011) Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors. J. Biol. Chem. 286, 3967539682.
  • Hirota Y., Acar N., Tranguch S. et al. (2010) Uterine FK506-binding protein 52 (FKBP52)-peroxiredoxin-6 (PRDX6) signaling protects pregnancy from overt oxidative stress. Proc. Natl Acad. Sci. USA 107, 1557715582.
  • Holsboer F. (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477501.
  • Hong J., Kim S. T., Tranguch S., Smith D. F. and Dey S. K. (2007) Deficiency of co-chaperone immunophilin FKBP52 compromises sperm fertilizing capacity. Reproduction 133, 395403.
  • Horstmann S., Lucae S., Menke A., Hennings J. M., Ising M., Roeske D., Muller-Myhsok B., Holsboer F. and Binder E. B. (2010) Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment. Neuropsychopharmacology 35, 727740.
  • Hubler T. R. and Scammell J. G. (2004) Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 9, 243252.
  • Hubler T. R., Denny W. B., Valentine D. L., Cheung-Flynn J., Smith D. F. and Scammell J. G. (2003) The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 144, 23802387.
  • Ising M., Depping A. M., Siebertz A. et al. (2008) Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur. J. Neurosci. 28, 389398.
  • Kam J. C., Szefler S. J., Surs W., Sher E. R. and Leung D. Y. (1993) Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151, 34603466.
  • Kang C. B., Hong Y., Dhe-Paganon S. and Yoon H. S. (2008) FKBP family proteins: immunophilins with versatile biological functions. Neurosignals 16, 318325.
  • Kato T. (2007) Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci. 61, 319.
  • Kato T. (2008) Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium 44, 92102.
  • de Kloet E. R. (2003) Hormones, brain and stress. Endocr. Regul. 37, 5168.
  • de Kloet E. R., Joels M. and Holsboer F. (2005) Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463475.
  • Klok M. D., Vreeburg S. A., Penninx B. W., Zitman F. G., de Kloet E. R. and DeRijk R. H. (2011) Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: interaction with SSRIs. Psychoneuroendocrinology 36, 484494.
  • Koenen K. C., Saxe G., Purcell S. et al. (2005) Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry 10, 10581059.
  • Kokras N., Dalla C. and Papadopoulou-Daifoti Z. (2011) Sex differences in pharmacokinetics of antidepressants. Expert Opin. Drug Metab. Toxicol. 7, 213226.
  • Kuhlmann S., Piel M. and Wolf O. T. (2005) Impaired memory retrieval after psychosocial stress in healthy young men. J. Neurosci. 25, 29772982.
  • Lee R. S., Tamashiro K. L., Yang X. et al. (2010) Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology 151, 43324343.
  • Lekman M., Laje G., Charney D. et al. (2008) The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol. Psychiatry, 63, 11031110.
  • Li T. K., Baksh S., Cristillo A. D. and Bierer B. E. (2002) Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin. J. Cell. Biochem. 84, 460471.
  • Li H., Rao A. and Hogan P. G. (2011) Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 21, 91103.
  • Lovas K., Gjesdal C. G., Christensen M. et al. (2009) Glucocorticoid replacement therapy and pharmacogenetics in Addison’s disease: effects on bone. Eur. J. Endocrinol. 160, 9931002.
  • Makkonen H., Kauhanen M., Paakinaho V., Jaaskelainen T. and Palvimo J. J. (2009) Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res. 37, 41354148.
  • Marques A. H., Silverman M. N. and Sternberg E. M. (2009) Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann. N. Y. Acad. Sci. 1179, 118.
  • Massol N., Lebeau M. C., Schumacher M. and Baulieu E. E. (2003) Promoter activity and gene structure of rabbit FKBP52. DNA Cell Biol. 22, 505511.
  • Nestler E. J., Barrot M., DiLeone R. J., Eisch A. J., Gold S. J. and Monteggia L. M. (2002) Neurobiology of depression. Neuron 34, 1325.
  • Oishi K., Miyazaki K., Kadota K. et al. (2003) Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J. Biol. Chem. 278, 4151941527.
  • Oitzl M. S., Reichardt H. M., Joels M. and de Kloet E. R. (2001) Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc. Natl Acad. Sci. USA 98, 1279012795.
  • Oitzl M. S., Champagne D. L., van der Veen R. and de Kloet E. R. (2010) Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci. Biobehav. Rev. 34, 853866.
  • Ozer E. J., Best S. R., Lipsey T. L. and Weiss D. S. (2003) Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol. Bull. 129, 5273.
  • Paakinaho V., Makkonen H., Jaaskelainen T. and Palvimo J. J. (2010) Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol. Endocrinol. 24, 511525.
  • Pariante C. M. and Miller A. H. (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49, 391404.
  • Pariante C. M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A. H. and Kerwin R. W. (2001) Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br. J. Pharmacol. 134, 13351343.
  • Periyasamy S., Hinds Jr T.., Shemshedini L., Shou W. and Sanchez E. R. (2010) FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. Oncogene 29, 16911701.
  • Perrot-Applanat M., Cibert C., Geraud G., Renoir J. M. and Baulieu E. E. (1995) The 59 kDa FK506-binding protein, a 90 kDa heat shock protein binding immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus. J. Cell Sci. 108, 20372051.
  • Piwien Pilipuk G., Vinson G. P., Sanchez C. G. and Galigniana M. D. (2007) Evidence for NL1-independent nuclear translocation of the mineralocorticoid receptor. Biochemistry 46, 13891397.
  • Piwien-Pilipuk G. and Galigniana M. D. (1998) Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor. Mol. Cell. Endocrinol. 144, 119130.
  • Piwien-Pilipuk G. and Galigniana M. D. (2000) Oxidative stress induced by L-buthionine-(S,R)-sulfoximine, a selective inhibitor of glutathione metabolism, abrogates mouse kidney mineralocorticoid receptor function. Biochim. Biophys. Acta 1495, 263280.
  • Piwien-Pilipuk G., Ayala A., Machado A. and Galigniana M. D. (2002) Impairment of mineralocorticoid receptor (MR)-dependent biological response by oxidative stress and aging: correlation with post-translational modification of MR and decreased ADP-ribosylatable level of elongating factor 2 in kidney cells. J. Biol. Chem. 277, 1189611903.
  • Pratt W. B. and Toft D. O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306360.
  • Quintá H. R. and Galigniana M. D. (2012) The Neuroregenerative Mechanism Mediated by the Hsp90-Binding Immunophilin Fkbp52 Resembles the Early Steps of Neuronal Differentiation. Br. J. Pharmacol. 166, 637649.
  • Quintá H. R., Maschi D., Gomez-Sanchez C., Piwien Pilipuk G. and Galigniana M. D. (2010) Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth. J. Neurochem. 115, 716734.
  • Quintá H. R., Galigniana N. M., Erlejman A. G., Lagadari M., Piwien-Pilipuk G. and Galigniana M. D. (2011) Management of cytoskeleton architecture by molecular chaperones and immunophilins. Cell. Signal. 23, 19071920.
  • Raddatz D., Middel P., Bockemuhl M., Benohr P., Wissmann C., Schworer H. and Ramadori G. (2004) Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis. Aliment. Pharmacol. Ther. 19, 4761.
  • Reiche E. M., Nunes S. O. and Morimoto H. K. (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5, 617625.
  • Reynolds P. D., Roveda K. P., Tucker J. A., Moore C. M., Valentine D. L. and Scammell J. G. (1998) Glucocorticoid-resistant B-lymphoblast cell line derived from the Bolivian squirrel monkey (Saimiri boliviensis boliviensis). Lab. Anim. Sci. 48, 364370.
  • Ridder S., Chourbaji S., Hellweg R. et al. (2005) Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 25, 62436250.
  • Riggs D. L., Roberts P. J., Chirillo S. C., Cheung-Flynn J., Prapapanich V., Ratajczak T., Gaber R., Picard D. and Smith D. F. (2003) The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J. 22, 11581167.
  • Riggs D. L., Cox M. B., Tardif H. L., Hessling M., Buchner J. and Smith D. F. (2007) Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling. Mol. Cell. Biol. 27, 86588669. Epub 20070Oct 8615.
  • van Rossum E. F., Binder E. B., Majer M., Koper J. W., Ising M., Modell S., Salyakina D., Lamberts S. W. and Holsboer F. (2006) Polymorphisms of the glucocorticoid receptor gene and major depression. Biol. Psychiatry 59, 681688.
  • Roy A., Gorodetsky E., Yuan Q., Goldman D. and Enoch M. A. (2010) Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35, 16741683.
  • Sapolsky R. M., Krey L. C. and McEwen B. S. (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7, 284301.
  • Sarginson J. E., Lazzeroni L. C., Ryan H. S., Schatzberg A. F. and Murphy Jr G. M. (2010) FKBP5 polymorphisms and antidepressant response in geriatric depression. Am J. Med. Genet. B Neuropsychiatr. Genet. 153B, 554560.
  • Scammell J. G., Denny W. B., Valentine D. L. and Smith D. F. (2001) Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen. Comp. Endocrinol. 124, 152165.
  • Scammell J. G., Hubler T. R., Denny W. B. and Valentine D. L. (2003) Organization of the human FK506-binding immunophilin FKBP52 protein gene (FKBP4). Genomics 81, 640643.
  • Schiene-Fischer C., Aumuller T. and Fischer G. (2012) Peptide Bond cis/trans Isomerases: a Biocatalysis Perspective of Conformational Dynamics in Proteins. Top. Curr. Chem. 133.
  • Schmidt U., Holsboer F. and Rein T. (2011) Epigenetic aspects of posttraumatic stress disorder. Dis. Markers 30, 7787.
  • Schule C., Baghai T. C., Eser D., Hafner S., Born C., Herrmann S. and Rupprecht R. (2009) The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression. PLoS ONE 4, e4324.
  • Segman R. H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N. and Shalev A. Y. (2005) Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 10, 500-513, 42, 500513, 425.
  • Sherry B., Zybarth G., Alfano M. et al. (1998) Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. Proc. Natl Acad. Sci. USA 95, 17581763.
  • Shibuya N., Suzuki A., Sadahiro R., Kamata M., Matsumoto Y., Goto K., Hozumi Y. and Otani K. (2010) Association study between a functional polymorphism of FK506-binding protein 51 (FKBP5) gene and personality traits in healthy subjects. Neurosci. Lett. 485, 194197.
  • Shim S., Yuan J. P., Kim J. Y. et al. (2009) Peptidyl-prolyl isomerase FKBP52 controls chemotropic guidance of neuronal growth cones via regulation of TRPC1 channel opening. Neuron 64, 471483.
  • Silverstein A. M., Galigniana M. D., Kanelakis K. C., Radanyi C., Renoir J. M. and Pratt W. B. (1999) Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein. J. Biol. Chem. 274, 3698036986.
  • Sinars C. R., Cheung-Flynn J., Rimerman R. A., Scammell J. G., Smith D. F. and Clardy J. (2003) Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc. Natl Acad. Sci. USA 100, 868873.
  • Sivils J. C., Storer C. L., Galigniana M. D. and Cox M. B. (2011) Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52). Curr. Opin. Pharmacol. 11, 314319.
  • Soontornniyomkij V., Everall I. P. and Moore D. J. et al. (2012) Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders. J. Neurovirol. DOI: 10.1007/s13365-011-0076-8.
  • Stechschulte L. A. and Sanchez E. R. (2011) FKBP51-a selective modulator of glucocorticoid and androgen sensitivity. Curr. Opin. Pharmacol. 11, 332337.
  • Szymanska M., Budziszewska B., Jaworska-Feil L., Basta-Kaim A., Kubera M., Leskiewicz M., Regulska M. and Lason W. (2009) The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 34, 822832.
  • Takahashi N., Hayano T. and Suzuki M. (1989) Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337, 473475.
  • Tamura M., Sajo M., Kakita A., Matsuki N. and Koyama R. (2011) Prenatal stress inhibits neuronal maturation through downregulation of mineralocorticoid receptors. J. Neurosci. 31, 1150511514.
  • Tatro E. T., Everall I. P., Kaul M. and Achim C. L. (2009a) Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res. 1286, 112.
  • Tatro E. T., Everall I. P., Masliah E., Hult B. J., Lucero G., Chana G., Soontornniyomkij V. and Achim C. L. (2009b) Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder. J. Neuroimmune. Pharmacol. 4, 218226.
  • Thomas M., Harrell J. M., Morishima Y., Peng H. M., Pratt W. B. and Lieberman A. P. (2006) Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Hum. Mol. Genet. 15, 18761883.
  • Touma C., Gassen N. C., Herrmann L. et al. (2011) FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry 70, 928936.
  • Tranguch S., Cheung-Flynn J., Daikoku T. et al. (2005) Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc. Natl Acad. Sci. USA 102, 1432614331, Epub 12005 Sep 14321..
  • Tranguch S., Wang H., Daikoku T., Xie H., Smith D. F. and Dey S. K. (2007) FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific. J. Clin. Invest. 117, 18241834.
  • Ulrich-Lai Y. M. and Herman J. P. (2009) Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 10, 397409.
  • Vermeer H., Hendriks-Stegeman B. I., van der Burg B., van Buul-Offers S. C. and Jansen M. (2003) Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab. 88, 277284.
  • Vicent G. P., Monteserin M. C., Veleiro A. S., Burton G., Lantos C. P. and Galigniana M. D. (1997) 21-Hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific antiglucocorticoid properties in the rat. Mol. Pharmacol. 52, 749753.
  • Vicent G. P., Pecci A., Ghini A., Piwien-Pilipuk G. and Galigniana M. D. (2002) Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses. Exp. Cell Res. 276, 142154.
  • Warrier M., Hinds Jr T. D.., Ledford K. J. et al. (2010) Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice. Endocrinology 151, 32253236.
  • Watson S., Gallagher P., Del-Estal D., Hearn A., Ferrier I. N. and Young A. H. (2002) Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol. Med. 32, 10211028.
  • Weiwad M., Edlich F., Kilka S., Erdmann F., Jarczowski F., Dorn M., Moutty M. C. and Fischer G. (2006) Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins. Biochemistry 45, 1577615784.
  • Wiederrecht G., Hung S., Chan H. K. et al. (1992) Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex. J. Biol. Chem. 267, 2175321760.
  • Willour V. L., Chen H., Toolan J. et al. (2009) Family-based association of FKBP5 in bipolar disorder. Mol. Psychiatry 14, 261268.
  • Wochnik G. M., Ruegg J., Abel G. A., Schmidt U., Holsboer F. and Rein T. (2005) FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem. 280, 46094616.
  • Wohleb E. S., Hanke M. L., Corona A. W., Powell N. D., Stiner L. M., Bailey M. T., Nelson R. J., Godbout J. P. and Sheridan J. F. (2011) beta-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 62776288.
  • Wolf O. T. (2009) Stress and memory in humans: twelve years of progress? Brain Res. 1293, 142154.
  • Wu B., Li P., Liu Y. et al. (2004) 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex. Proc. Natl Acad. Sci. USA 101, 83488353.
  • Xie P., Kranzler H. R., Poling J., Stein M. B., Anton R. F., Farrer L. A. and Gelernter J. (2010) Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35, 16841692.
  • Xu X., Su B., Barndt R. J. et al. (2002) FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. Transplantation 73, 18351838.
  • Yang Z., Wolf I. M., Chen H. et al. (2006) FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform. Mol. Endocrinol. 20, 26822694, Epub 2006 Jul 2627.
  • Yehuda R. and LeDoux J. (2007) Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron 56, 1932.
  • Yehuda R., Golier J. A., Yang R. K. and Tischler L. (2004) Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 55, 11101116.
  • Yong W., Yang Z., Periyasamy S. et al. (2007) Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology. J. Biol. Chem. 282, 50265036, Epub 2006 Dec 5021.
  • Zhao W., Zhong L., Wu J. et al. (2006) Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. Virology, 353, 283293.